SEC Form 4 · accession 0001127602-17-006618
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Richard Brudnick
Officer — EVP, Business Development
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1 | $44.51 | Feb 14, 2017 | A | 29,744 | A | — | Feb 14, 2027 | Common Stock | 29,744 | 29,744 | D |
| Restricted Stock UnitsF2,F3 | — | Feb 14, 2017 | A | 11,233 | A | — | — | Common Stock | 11,233 | 11,233 | D |
| Non-Qualified Stock OptionF4 | $44.51 | Feb 14, 2017 | A | 59,488 | A | — | Feb 14, 2027 | Common Stock | 59,488 | 59,488 | D |
| Non-Qualified Stock OptionF1 | $44.51 | Feb 14, 2017 | A | 14,872 | A | — | Feb 14, 2027 | Common Stock | 14,872 | 14,872 | D |
Explanation of responses
- F1This option vests in three equal annual installments beginning on February 14, 2018.
- F2Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F3The restricted stock units vest in three equal annual installments beginning on February 14, 2018.
- F4This option vests in full on the third anniversary of the date of grant.